Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Arizona
With
National Cancer Institute (NCI)
University of California, Los Angeles
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Study participants who received one booster dose of Gardasil 9 at month 24 and elected not to receive the second booster at month 30 in the original "HPV vaccine delayed booster trial"
Ability to understand and the willingness to sign a written informed consent document by the legal representative(s) of the participant.
Ability to understand and the willingness to sign a written assent document by the participant.
You may not be if
\- Has received any HPV vaccine dose from an external source at any point during or after participation in the HPV vaccine delayed booster trial.
Clareo Health | An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial
